30/03/2014 - 19:35
WASHINGTON – The novel low-density lipoprotein cholesterol–lowering agent evolocumab took day 1 of the annual meeting of the American College of Cardiology by storm on the strength of three...
Field of Interest: Cardiology
Categories:
News Feed: Internal Medicine News - Cardiology